Stock Scorecard
Stock Summary for Madrigal Pharmaceuticals Inc (MDGL) - $293.64 as of 1/17/2025 9:07:40 PM EST
Total Score
7 out of 30
Safety Score
54 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MDGL
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MDGL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MDGL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MDGL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MDGL (54 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for MDGL
Financial Details for MDGL
Company Overview |
|
|---|---|
| Ticker | MDGL |
| Company Name | Madrigal Pharmaceuticals Inc |
| Country | USA |
| Description | Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/26/2025 |
Stock Price History |
|
| Last Day Price | 293.64 |
| Price 4 Years Ago | 84.74 |
| Last Day Price Updated | 1/17/2025 9:07:40 PM EST |
| Last Day Volume | 862,519 |
| Average Daily Volume | 360,608 |
| 52-Week High | 368.29 |
| 52-Week Low | 168.25 |
| Last Price to 52 Week Low | 74.53% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.55 |
| Sector PE | 41.18 |
| 5-Year Average PE | -11.73 |
| Free Cash Flow Ratio | 6.38 |
| Industry Free Cash Flow Ratio | 11.72 |
| Sector Free Cash Flow Ratio | 27.18 |
| Current Ratio Most Recent Quarter | 5.98 |
| Total Cash Per Share | 46.02 |
| Book Value Per Share Most Recent Quarter | 35.64 |
| Price to Book Ratio | 8.24 |
| Industry Price to Book Ratio | 4.87 |
| Sector Price to Book Ratio | 20.52 |
| Price to Sales Ratio Twelve Trailing Months | 83.38 |
| Industry Price to Sales Ratio Twelve Trailing Months | 81.24 |
| Sector Price to Sales Ratio Twelve Trailing Months | 24.40 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 21,810,400 |
| Market Capitalization | 6,404,405,856 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 10.80% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -26.49% |
| Reported EPS 12 Trailing Months | -26.96 |
| Reported EPS Past Year | -19.40 |
| Reported EPS Prior Year | -19.94 |
| Net Income Twelve Trailing Months | -518,670,000 |
| Net Income Past Year | -373,600,000 |
| Net Income Prior Year | -295,350,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | -187.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,003,627,000 |
| Total Cash Past Year | 634,131,000 |
| Total Cash Prior Year | 358,774,000 |
| Net Cash Position Most Recent Quarter | 886,540,000 |
| Net Cash Position Past Year | 518,651,000 |
| Long Term Debt Past Year | 115,480,000 |
| Long Term Debt Prior Year | 69,675,000 |
| Total Debt Most Recent Quarter | 117,087,000 |
| Equity to Debt Ratio Past Year | 0.78 |
| Equity to Debt Ratio Most Recent Quarter | 0.87 |
| Total Stockholder Equity Past Year | 405,333,000 |
| Total Stockholder Equity Prior Year | 197,389,000 |
| Total Stockholder Equity Most Recent Quarter | 777,155,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -438,322,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -20.10 |
| Free Cash Flow Past Year | -325,709,000 |
| Free Cash Flow Prior Year | -225,074,000 |
Options |
|
| Put/Call Ratio | 0.36 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -2.69 |
| MACD Signal | 1.43 |
| 20-Day Bollinger Lower Band | 178.77 |
| 20-Day Bollinger Middle Band | 279.60 |
| 20-Day Bollinger Upper Band | 380.44 |
| Beta | -0.47 |
| RSI | 34.27 |
| 50-Day SMA | 259.15 |
| 150-Day SMA | 196.44 |
| 200-Day SMA | 170.77 |
System |
|
| Modified | 1/19/2025 1:36:33 AM EST |